Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors
Clinical trial NCT04169321 · COMPLETED
Trial details
- NCT number
- NCT04169321
- Sponsor
- Cytosite Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2025-03-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.